Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 1
1989 6
1991 3
1992 2
1993 1
1994 3
1995 3
1996 2
1997 4
1998 5
1999 2
2000 2
2001 1
2002 5
2003 3
2004 2
2005 8
2006 5
2007 7
2008 6
2009 4
2010 4
2011 8
2012 4
2013 5
2014 4
2015 6
2016 8
2017 5
2018 10
2019 14
2020 13
2021 17
2022 16
2023 16
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim HR, Ueno M, Mansoor W, Yang WC, Liu T, Bridgewater J, Makino T, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y; CheckMate 648 Trial Investigators. Doki Y, et al. N Engl J Med. 2022 Feb 3;386(5):449-462. doi: 10.1056/NEJMoa2111380. N Engl J Med. 2022. PMID: 35108470 Clinical Trial.
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma.
Yang W, Xing X, Yeung SJ, Wang S, Chen W, Bao Y, Wang F, Feng S, Peng F, Wang X, Chen S, He M, Zhang N, Wang H, Zeng B, Liu Z, Kidane B, Seder CW, Koyanagi K, Shargall Y, Luo H, Peng S, Cheng C. Yang W, et al. Among authors: koyanagi k. J Immunother Cancer. 2022 Jan;10(1):e003497. doi: 10.1136/jitc-2021-003497. J Immunother Cancer. 2022. PMID: 35022193 Free PMC article.
Immunotherapy for esophageal cancer: Where are we now and where can we go.
Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Ninomiya Y, Yamamoto M, Kazuno A, Nabeshima K, Nishi T, Mori M. Shoji Y, et al. Among authors: koyanagi k. World J Gastroenterol. 2024 May 21;30(19):2496-2501. doi: 10.3748/wjg.v30.i19.2496. World J Gastroenterol. 2024. PMID: 38817664 Free PMC article. Review.
Adenovirus-Associated Uveitis with Necrotizing Retinitis.
Sugita S, Usui Y, Watanabe H, Panto L, Iida M, Suginoshita K, Koyanagi KO, Nishida A, Kurimoto Y, Takahashi M, Shindo T, Nishioka H, Takano M, Kezuka T, Goto H, Kitaichi N. Sugita S, et al. Among authors: koyanagi ko. Ophthalmology. 2023 Apr;130(4):443-445. doi: 10.1016/j.ophtha.2022.12.020. Epub 2022 Dec 23. Ophthalmology. 2023. PMID: 36572255 No abstract available.
Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review.
Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Yatabe K, Yamamoto M, Kazuno A, Nabeshima K, Nakamura K, Nishi T, Mori M. Shoji Y, et al. Among authors: koyanagi k. World J Gastroenterol. 2023 Jun 28;29(24):3758-3769. doi: 10.3748/wjg.v29.i24.3758. World J Gastroenterol. 2023. PMID: 37426325 Free PMC article. Review.
Conversion surgery for esophageal and esophagogastric junction cancer.
Shoji Y, Kanamori K, Koyanagi K, Otsuka T, Nakashima R, Tajima K, Ogimi M, Ninomiya Y, Yamamoto M, Kazuno A, Nishi T, Mori M. Shoji Y, et al. Among authors: koyanagi k. Int J Clin Oncol. 2024 Oct 22. doi: 10.1007/s10147-024-02639-4. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39436571 Review.
201 results